M235T angiotensinogen gene polymorphism and cardiovascular renal risk

Journal of Hypertension

Volumn 17, Issue 1, 1999, Pages 9-17

  Staessen, Jan A ^a,b   Kuznetsova, Tatyana ^a   Wang, Ji G ^a   Emelianov, Dmitri ^a   Vlietinck, Robert ^a   Fagard, Robert ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Angiotensinogen; Cardiomyopathy; Coronary heart disease; Genetic polymorphism; Hypertension; Myocardium; Nephropathy; Stroke

Indexed keywords

ANGIOTENSINOGEN;

ALLELE; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; DNA POLYMORPHISM; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HYPERTENSION; META ANALYSIS; PRIORITY JOURNAL; RISK;

EID: 0032975096     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199917010-00003     Document Type: Article

References (95)

1. Gaillard I, Clauser E, Corvol P. Structure of the human angiotensinogen gene. DNA 1989; 8:87-99.
2. Jeunemaitre X, Inoue I, William C, Charru A, Tichet J, Powers M, et al. Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet 1997; 60: 1448-1460.
3. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71:169-180.
4. Staessen JA, Wang JG, Ginocchio G, Petrov V, Saavedra AP, Soubrier F, et al. The deletion/insertion polymorphism of the converting-enzyme and cardiovascular-renal risk. J Hypertens 1997; 15:1579-1592.
5. Kotelevtsev YV, Clauser E, Corvol P, Soubrier F. Dinucleotide repeat polymorphism in the human angiotensinogen gene. Nucleic Acids Res 1991; 19:6978.
6. Iwai N, Ohmichi N, Nakamura Y, Mitsunami K. Kinoshita M. Molecular variants of the angiotensinogen gene and hypertension in a Japanese population. Hypertens Res 1994; 17:117-121.
7. Iwai N, Shimoike H, Ohmichi N, Kinoshita M. Angiotensinogen gene and blood pressure in the Japanese population. Hypertension 1995; 25:688-693.
8. Ohmichi N, Iwai N, Maeda K, Shimoike H, Nakamura Y, Izumi M, et al. Genetic basis of left ventricular remodeling after myocardial infarction. Int J Cardiol 1996; 53:265-272.
9. Rutledge D, Browe C, Kubilis P, Ross E. Analysis of two variants of the angiotensinogen gene in essential hypertensive African-Americans. Am J Hypertens 1994; 7:651-654.
10. Rutledge DR, Browe CS, Ross EA. Frequencies of the angiotensinogen gene and angiotensin I converting anzyme (ACE) gene in African Americans. Biochem Mol Biol Int 1994; 34:1271-1275.
11. Schmidt S, Sharma AM, Zilch O, Beige J, Walla-Friedel M, Ganten D, et al. Association of M235T variant of the angiotensinogen gene with familial hypertension of early onset. Nephrol Dial Transplant 1995; 10:1145-1148.
12. Russ AP, Maerz W, Ruzicka V, Stein U, Gross W. Rapid detection of the hypertension-associated Met-235-Thr allele of the human angiotensinogen gene. Hum Mol Genet 1993; 2:609-610.
13. Khoury MJ, Beaty TH, Cohen BH. Fundamentals of genetic epidemiology. Oxford: Oxford University Press; 1993.
14. Staessen JA, Ginocchio G, Wang JG, Saavedra AP, Soubrier F, Vlietinck R, et al. Genetic variability in the renin-angiotensin system: prevalence of alleles and genotypes. J Cardiovasc Risk 1997; 4:401-422.
15. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22:719-748.
16. Breslow NE, Day NE. Statistical methods in cancer research, vol 1. The analysis of case-control studies, IARC Scientific Publication 32. Lyon: International Agency for Research on Cancer; 1980.
17. Dickersin K, Berlin JA. Meta-analysis: state-of-the-art science. Epidemiol Rev 1992; 14:154-176.
18. Hedges LV, Olkin I. Tests of statistical significance of combined results. In: Statistical methods for meta-analysis, 1st ed. San Diego, California: Academic Press; 1985, pp. 28-47.
19. Caulfield M, Lavender P, Farrall M, Munroe P, Lawson M, Turner P, et al. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994; 330:1629-1633.
20. Hata A, Namikawa C, Sasaki M, Sato K, Nakamura T, Tamura K, et al. Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest 1994; 93:1285-1287.
21. Katsuya T, Koike G, Yee TW, Sharpe N, Jackson R, Norton R, et al. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet 1995; 345:1600-1603.
22. Tiret L, Ricard S, Poirier O, Arveiler D, Cambou JP, Luc G, et al. Genetic variation of the angiotensinogen locus in relation to high blood pressure and myocardial infarction: the ECTIM study. J Hypertens 1995; 13:311-317.
23. Ward K, Hata A, Jeunemaitre X, Helin C, Nelson L, Namikawa C, et al. A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet 1993; 4:59-61.
24. Rotimi C, Puras A, Cooper R, McFarlane-Anderson N, Forrester T, Ogunbiyi O, et al. Polymorphisms of renin-angiotensin genes among Nigerians, Jamaicans, and African Americans. Hypertension 1996; 27:558-563.
25. Dudley C, Keavney B, Casadei B, Conway J, Bird R, Ratcliffe P. Prediction of patient responses to antihypertensive drugs using genetic polymorphisms: investigation of renin-angiotensin system genes. J Hypertens 1996; 14:259-262.
26. Bennett CL, Schrader AP, Morris BJ. Cross-sectional analysis of Met-235-Thr variant of angiotensinogen gene in severe, familial hypertension. Biochem Biophys Res Commun 1993; 197:833-839.
27. Doria A, Onuma T, Gearin G, Freire MBS, Warram JH, Krolewski AS. Angiotensinogen polymorphism M235T, hypertension, and nephropathy in insulin-dependent diabetes. Hypertension 1996; 27:1134-1139.
28. Hegele RA, Brunt JH, Connell JMC. A polymorphism of the angiotensinogen gene associated with variation in blood pressure in a genetic isolate. Circulation 1994; 90:2207-2212.
29. Forrester T, Cooper R, Bennet F, McFarlane-Anderson N, Puras A, Rotimi C, et al. Angiotensinogen and blood pressure among blacks: findings from a community survey in Jamaica. J Hypertens 1996; 14:315-321.
30. Rotimi C, Morrison L, Cooper R, Oyejide C, Effiong E, Lapido M, et al. Angiotensinogen gene in human hypertension: lack of an association of the 235T allele among African Americans. Hypertension 1994; 24:591-594.
31. Kamitani A, Rakugi H, Higaki J, Yi Z, Mikami H, Miki T, et al. Association analysis of a polymorphism of the angiotensinogen gene with essential hypertension in Japanese. J Hum Hypertens 1994; 8:521-524.
32. Dudley CRK, Keavney B, Stratton IM, Turner RC, Ratcliffe PJ. UK Prospective Diabetes Study XV: relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM. Kidney Int 1995; 48:1907-1911.
33. Marre M. Jeunemaitre X, Gallois Y, Rodier M, Chatellier G, Sert C, et al. Contribution of genetic polymorphisms in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Génètique de la Néphropathie Diabétique (GENEDIAB) Study Group. J Clin Invest 1997; 99:1585-1595.
34. Caulfield M, Lavender P, Newell-Price J, Farrall M, Kamdar S, Daniel H, et al. Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans. J Clin Invest 1995; 96:687-692.
35. Kamitani A, Rakugi H, Higaki J, Ohishi M, Shi SJ, Takami S, et al. Enhanced predictability of myocardial infarction in Japanese by combined genotype analysis. Hypertension 1995; 25:950-953.
36. 235-Thr variant on blood pressure and other cardiovascular risk factors in two Japanese populations. J Hypertens 1995; 13:717-722.
37. Ishigami T, Umemura S, Iwamoto T, Tamura K, Hibi K, Yamaguchi S, et al. Molecular variant of angiotensinogen gene is associated with coronary atherosclerosis. Circulation 1995; 91:951-954.
38. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Ricard S, et al. Angiotensinogen gene polymorphisms in IDDM patients with diabetic nephropathy. Diabetes 1996; 45:367-369.
39. Fogarty DG, Hughes AE, Nevin NC, Doherty CC, Maxwell AP. Functional genetic markers of the renin-angiotensin system and the risk of diabetic retinopathy in insulin-dependent diabetes mellitus [abstract]. J Am Soc Nephrol 1994; 5:376.
40. Grim CE, Lifton RP, Wilson TW. Viswanathan A, Etienne C, Wilson DM, et al. The angiotensinogen gene MT235 is not associated with blood pressure in blacks on Dominica [abstract]. Hypertension 1994; 24:381.
41. Yoshida H, Kuriyama S, Atsumi Y, Tomonari H, Mitarai T, Hamaguchi A, et al. Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus. Kidney Int 1996; 50:657-664.
42. Schmidt S, Giessel R, Bergis KH, Strojek K, Grzeszczak W, Ganten D, et al. Angiotensinogen gene M235T polymorphism is not associated with diabetic nephropathy. Nephrol Dial Transplant 1996; 11:1755-1761.
43. Beige J, Weber A, Engeli S, Offerman G, Distler A, Sharma AM. Angiotensinogen-M235T genotype and post-transplant hypertension. Nephrol Dial Transplant 1996; 11:1538-1541.
44. 235-Thr polymorphism in a London normotensive and hypertensive black and white population. J Hum Hypertens 1994; 8:639-640.
45. Hunley TE, Julian BA, Phillips JA, III, Summar ML, Yoshida H, Horn RG, et al. Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy. Kidney Int 1996; 49:571-577.
46. Jeunemaitre X, Charru A, Chatellier G, Dumont C, Sassano P, Soubrier F, et al. M235T variant of the human angiotensinogen gene in unselected hypertensive patients. J Hypertens 1993; 11 (suppl 5):S80-S81.
47. McLaughlin KJ, Jagger C, Small M, Jardine AG. Effect of angiotensinogen gene T235 variant on the development of diabetic complications in type II diabetes mellitus [letter]. Lancet 1995; 346:1160.
48. Chowdhury TA, Dronsfield MJ, Kumar S, Gough SLC, Gibson SP, Khatoon A, et al. Examination of two genetic polymorphisms within the renin-angiotensin system: no evidence for an association with diabetic nephropathy in IDDM. Diabetologia 1996; 39:1108-1114.
49. Fogarty DG, Harron JC, Hughes AE, Nevin NC, Doherty CC, Maxwell AP. A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM. Diabetes 1996; 45:1204-1208.
50. Fornage M, Turner ST, Sing CF, Boerwinkle E. Variation at the M235T locus of the angiotensinogen gene and essential hypertension: a population-based case-control study from Rochester, Minnesota. Hum Genet 1995; 96:295-300.
51. Johnson AG, Simons LA, Friedlander Y, Simons J, Davis DR. MaCallum J. M235-T polymorphism of the angiotensonogen gene predicts hypertension in the elderly. J Hypertens 1996; 14:1061-1065.
52. Hingorani AD, Sharma P, Jia H, Hopper R, Brown MJ. Blood pressure and the M235T polymorphism of the angiotensiongen gene. Hypertension 1996; 28:907-911.
53. Hopkins PN, Lifton RP, Hollenberg NK, Jeunemaitre X, Hallouin MC, Skippin J, et al. Blunted renal vascular response to angiotonsin II is associated with a common variant of angiotensinogen and obesity. J Hypertens 1996; 14:199-207.
54. Yamakawa-Kobayashi K, Arinami T, Hamaguchi H. Absence of association of angiotensinogen gene T235 allele with increased risk of coronary heart disease in Japanese. Lancet 1995; 346:515.
55. Kiema TR, Kauma H, Rantala AO, Lilja M, Reunanen A, Kesäniemi YA, et al. Variation at angiotensin-converting enzyme gene and angiotensinogen gene loci in relation to blood pressure. Hypertension 1996; 28:1070-1075.
56. Schunkert H, Hense HW, Gimenez-Roqueplo AP, Stiebor J, Keil U, Riegger GAJ, et al. The angiotensinogen T235 variant and the use of antihypertensive drugs in a population-based cohort. Hypertension 1997; 29:628-633.
57. Busjahn A, Knoblauch H, Knoblauch M, Bohlender J, Menz M, Faulhaber HD, et al. Angiotensin-converting enzyme and angiotensinogen gene polymorphisms, plasma levels, cardiac dimensions: a twin study. Hypertension 1997; 29:155-170.
58. Beige J, Zilch O, Hohenbleicher H. Ringel J, Kunz R, Distler A, et al. Genetic variants of the renin-angiotensin system and the ambulatory blood pressure in essential hypertension. J Hypertens 1997; 15:503-508.
59. Cooper R, McFarlane-Anderson N, Bennett FI, Wilks R, Puras A, Tewksbury D, et al. ACE, angiotensinogen and obesity: a potential way leading to hypertension, J Hum Hypertens 1997; 11:107-111.
60. Rotimi C, Cooper R, Ogunbiyi O, Morrison L, Lapido M, Tewksbury D, et al. Hypertension, serum angiotensinogen, and molecular variants of the angiotensinogen gene among Nigerians. Circulation 1997; 95:2348-2350.
61. Lesage S, Velho G, Vionnet N, Chatelain N, Demenais F, Passa P, et al. Genetic studies of the renin-angiotensin system in arterial hypertension associated with non-insulin dependent diabetes mellitus. J Hypertens 1997; 15:601-606.
62. Chiang FT, Hsu XL, Tseng CD, Hsiao WH, Lo HM, Chern TH, et al. Molecular variant M235T of the angiotensinogen gene is associated with essential hypertension in Taiwanese. J Hypertens 1997; 15:607-611.
63. Gharavi AG, Lipkowitz MS, Diamond JA, Chamie R, Phillips RA. Ambulatory blood pressure monitoring for detecting the relation between angiotensinogen gene polymorphism and hypertension. Am J Hypertens 1997; 10:687-691.
64. Bigda J, Narkiewicz K, Chrostowska M, Winnicki M, Szczech R, Pawlowski R, et al. No effect of genetic variation at the angiotensionogen locus on ambulatory blood pressure level in normotensive subjects. Am J Hypertens 1997; 10:692-695.
65. Hegele RA, Harris SB, Hanley AJG, Sun F, Connelly PW, Zinman B. Angiotensinogen gene variation associated with variation in blood pressure in aboriginal Canadians. Hypertension 1997; 29:1073-1077.
66. Ko YL, Ko YS, Wang SM, Chu PH, Teng MS, Cheng NJ, et al. Angiotensinogen and angiotensin-1 converting enzyme gene polymorphisms and the risk of coronary artery disease in Chinese. Hum Genet 1997; 100:210-214.
67. Jeunemaitre X, Ledru F, Battaglia S, Guillanneuf MT, Courbon D, Dumont C, et al. Genetic polymorphisms of the renin-angiotensin system and angiographic extent and severity of coronary artery disease: the CORGENE study. Hum Genet 1997; 99:66-73.
68. Ludwig EH, Borecki IB, Ellison RC, Folsom AR, Heiss G, Higgins M, et al. Associations between candidate loci angiotensin-converting enzyme and angiotensinogen with coronary heart disease and myocardial infarction: the NHLBI Family Heart Study. Ann Epidemiol 1997; 7:3-12.
69. Borecki IB, Province MA, Ludwig EH, Ellison RC, Folsom AR, Heiss G, et al. Associations of candidate loci angiotensinogen and angiotensin-converting enzyme with severe hypertension: the NHLBI Family Heart Study. Ann Epidemiol 1997; 7:13-21.
70. Ringel J, Beige J, Kunz R, Distler A, Sharma AM. Genetic variants of the renin-angiotensin system, diabetic nephropathy and hypertension. Diabetologia 1997; 40; 193-199.
71. Sato N, Katsuya T, Rakugi H, Takami S, Nakata Y, Miki T, et al. Association of variants in critical core promoter element of angiotensinogen gene with increased risk of essential hypertension in Japanese. Hypertension 1997; 30 (part 1):321-325.
72. Yamada Y, Ichihara S, Fujimura T, Yokota M. Lack of association of polymorphisms of the angiotensin converting enzyme and angiotensinogen genes with nonfamilial hypertrophic or dilated cardiomyopathy. Am J Hypertens 1997; 10:921-928.
73. Pei Y, Scholey J, Thai K, Suzuki M, Cattran DC. Association of angiotensinogen gene T235 variant with progression of immunoglobulin A nephropathy in Caucasian patients. J Clin Invest 1997; 100:814-820.
74. Ishanov A, Okamoto H, Yoneya K, Watanabe M, Nakagawa I, Machida M, et al. Angiotensinogen polymorphism in Japanese patients with hypertrophic cardiomyopathy. Am Heart J 1997; 133:184-189.
75. Fardella CE, Claverie X, Vignolo P, Montero J, Villarroel L. T235 variant of the angiotensinogen gene is associated with low renin hypertension in a Chilean population. J Hypertens 1997; 16:829-833.
76. Nakata Y, Katsuya T, Rakugi H, Takami S, Sato N, Kamide K, et al. Polymorphism of angiotensin converting enzyme, angiotensinogen, and apolipoprotein E genes in a Japanese population with cerebrovascular disease. Am J Hypertens 1997; 10:1391-1395.
77. Tiret L, Blanc H, Ruidavets JB, Arveiler D, Luc G, Jeunemaitre X, et al. Gene polymorphisms of the renin-angiotensin system in relation to hypertension and parenteral history of myocardial infarction and stroke: the PEGASE study. J Hypertens 1998; 16:37-44.
78. Freire MBS, Ji L, Onuma T, Orban T, Warram JH, Krolewski AS. Gender-specific association of M235T polymorphism in angiotensinogen gene and diabetic nephropahy in NIDDM. Hypertension 1998; 31:896-899.
79. Mondorf UF, Russ A, Wiesemann A, Herrero M, Oremek G, Lenz T. Contribution of angiotensin I converting enzyme gene polymorphism and angiotensinogeen gene polymorphism to blood pressure regulation in essential hypertension. Am J Hypertens 1998; 11:174-183.
80. Barley J, Markus H, Brown M, Carter N. Lack of assocation between angiotensinogen polymorphism (M235T) and cerebrovascular disease and carotid atheroma. J Hum Hypertens 1995; 9:681-683.
81. Institute for Scientific Information. Science Citation Index: an International Interdisciplinary Index to the Literature of Science, Medicine, Agriculture, Technology, and the Behavioral and Social Sciences. Philadelphia: Institute for Scientific Information; 1994.
82. Cheung BMY, Leung R, Shiu S, Tan KCB, Lau CP, Kumana CR. M235T polymorphism of the angiotensinogen gene and hypertension in Chinese. J Hypertens 1998; 16:1137-1140.
83. Kunz R, Kreutz R, Beige J, Distler A, Sharma AM. Association between the angiotensinogen 235T-variant and essential hypertension in whites: a systematic review and methodological appraisal. Hypertension 1997; 30:1331-1337.
84. Greenland S. Quantitative methods in the review of the epidomiological literature. Epidemiol Rev 1987; 9:1-30.
85. Begg C, Cho M, Eastwood S, Horton R, Moher O, Olkin I, et al. Improving the quality of reporting of randomised controlled trials: the CONSORT statement. JAMA 1996; 276:637-639.
86. Bohlender J, Menard J, Wagner J, Luft FC, Ganten D. Human renin-dependent hypertension in rats transgenic for human angiotensinogen. Hypertension 1996; 27:535-540.
87. Caulfield M, Lavender P, Newell-Price J, Kamdar S, Farrall M, Clark AJL. Angiotensinogen in human essential hypertension. Hypertension 1996; 28:1123-1125.
88. Kim HS, Krege JH, Kluckman KD, Hagaman JR, Hodgkin JB, Best CF, et al. Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci USA 1995; 92:2635-2739.
89. Fukamizu A, Sugimura K, Takimoto E, Sugiyama F, Seo MS, Takahashi S, et al. Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes. J Biol Chem 1993; 268:11617-11621.
90. Smithies O. A mouse view of hypertension. Hypertension 1997; 30:1318-1324.
91. Fukamizu A, Takahashi S, Seo MS, Tada M, Tanimoto K, Uehara S, et al. Structure and expression of the human angiotensinogen gene: identification of a unique and highly active promoter. J Biol Chem 1989; 265:7576-7582.
92. Tamura K, Umemura S, Ishii M, Tanimoto K, Murakami K, Fukamizu A. Molecular mechanism of transcriptional activation of angiotensinogen gene by proximal promoter. J Clin Invest 1994; 93:1370-1379.
93. Yanai K, Nibu Y, Murakami K. Fukamizu A. A cis-acting DNA element located between TATA box and transcription initiation site is critical in response to regulatory sequences in human angiotensinogen gene. J Biol Chem 1996; 271:15981-15986.
94. Ishigami T, Umemura S, Tamura K, Hibi K, Nyui N, Kihara M, et al. Essential hypertension and 5′ upsteam core promoter region of human angiotensinogen gene. Hypertension 1997; 30:1325-1330.
95. Inoue I, Nakajima T, Williams CS, Quackenbush J, Puryear R, Powers M, et al. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 1997; 99:1786-1797.